Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-028599
Filing Date
2020-02-10
Accepted
2020-02-07 19:43:03
Documents
2
Group Members
ONYX PHARMACEUTICALS, INC.ONYX THERAPEUTICS, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d884160dsc13ga.htm SC 13G/A 59640
2 EXHIBIT 1 d884160dex991.htm EX-99.1 5029
  Complete submission text file 0001193125-20-028599.txt   66403
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Subject) CIK: 0001645666 (see all company filings)

EIN.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90539 | Film No.: 20588962
SIC: 2834 Pharmaceutical Preparations